GR3036738T3 - Immunomodulator, cell adhesion inhibitor, and agent for treating and preventing autoimmune diseases - Google Patents
Immunomodulator, cell adhesion inhibitor, and agent for treating and preventing autoimmune diseasesInfo
- Publication number
- GR3036738T3 GR3036738T3 GR20010401595T GR20010401595T GR3036738T3 GR 3036738 T3 GR3036738 T3 GR 3036738T3 GR 20010401595 T GR20010401595 T GR 20010401595T GR 20010401595 T GR20010401595 T GR 20010401595T GR 3036738 T3 GR3036738 T3 GR 3036738T3
- Authority
- GR
- Greece
- Prior art keywords
- cell adhesion
- autoimmune diseases
- disease
- autoimmune
- general formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10746493 | 1993-04-09 | ||
| PCT/JP1994/000585 WO1994023714A1 (en) | 1993-04-09 | 1994-04-07 | Immunomodulator, cell adhesion inhibitor, and agent for treating and preventing autoimmune diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3036738T3 true GR3036738T3 (en) | 2001-12-31 |
Family
ID=14459856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20010401595T GR3036738T3 (en) | 1993-04-09 | 2001-09-27 | Immunomodulator, cell adhesion inhibitor, and agent for treating and preventing autoimmune diseases |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5922755A (de) |
| EP (1) | EP0695547B1 (de) |
| JP (1) | JP3521145B2 (de) |
| KR (1) | KR960701633A (de) |
| AT (1) | ATE203904T1 (de) |
| AU (1) | AU698990B2 (de) |
| CA (1) | CA2159192C (de) |
| DE (1) | DE69427907T2 (de) |
| DK (1) | DK0695547T3 (de) |
| ES (1) | ES2160626T3 (de) |
| GR (1) | GR3036738T3 (de) |
| NZ (1) | NZ263620A (de) |
| PT (1) | PT695547E (de) |
| WO (1) | WO1994023714A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| US7001921B1 (en) | 1995-01-23 | 2006-02-21 | Biogen Idec Ma Inc. | Cell adhesion inhibitors |
| US6248713B1 (en) | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
| US6239108B1 (en) | 1996-07-11 | 2001-05-29 | Biogen, Inc. | Cell adhesion inhibitors |
| CA2261974A1 (en) | 1996-07-25 | 1998-02-05 | Biogen, Inc. | Molecular model for vla-4 inhibitors |
| US6686350B1 (en) | 1996-07-25 | 2004-02-03 | Biogen, Inc. | Cell adhesion inhibitors |
| SI1082302T1 (en) | 1998-05-28 | 2004-06-30 | Biogen, Inc. | A vla-4 inhibitor: omepupa-v |
| JP2001055331A (ja) * | 1999-06-11 | 2001-02-27 | Toyama Chem Co Ltd | アトピー性皮膚炎治療剤 |
| PL354063A1 (en) | 1999-08-13 | 2003-12-15 | Biogen, Inc.Biogen, Inc. | Cell adhesion inhibitors |
| AU2001289831A1 (en) * | 2000-09-06 | 2002-03-22 | Bayer Aktiengesellschaft | Medicaments against viral infections |
| US6875743B1 (en) | 2000-11-28 | 2005-04-05 | Biogen, Inc. | Cell adhesion inhibitors |
| GB0119865D0 (en) * | 2001-08-14 | 2001-10-10 | Cancer Res Campaign Tech | DNA-PK inhibitors |
| GB0119863D0 (en) * | 2001-08-14 | 2001-10-10 | Cancer Res Campaign Tech | DNA-PK inhibitors |
| JP3972663B2 (ja) * | 2002-01-22 | 2007-09-05 | 松下電器産業株式会社 | 高周波信号受信装置 |
| US7049313B2 (en) * | 2002-02-25 | 2006-05-23 | Kudos Pharmaceuticals Ltd. | ATM inhibitors |
| CN100387231C (zh) * | 2003-03-24 | 2008-05-14 | 天津药物研究院 | 一种制备古拉替莫固体制剂的工艺及其固体制剂 |
| CA2534300A1 (en) * | 2003-08-13 | 2005-02-24 | Kudos Pharmaceuticals Limited | Aminopyrones and their use as atm inhibitors |
| CN103356636A (zh) | 2004-05-23 | 2013-10-23 | 杰勒德·M·豪斯 | Theramutein调节剂 |
| US7196112B2 (en) * | 2004-07-16 | 2007-03-27 | Biogen Idec Ma Inc. | Cell adhesion inhibitors |
| UA88329C2 (en) | 2004-09-20 | 2009-10-12 | Кудос Фармасьютикалз Лимитед | Dna-pk inhibitors |
| JP2008529995A (ja) * | 2005-02-09 | 2008-08-07 | クドス ファーマシューティカルズ リミテッド | Ａｔｍ阻害剤 |
| AR053358A1 (es) * | 2005-04-15 | 2007-05-02 | Cancer Rec Tech Ltd | Inhibidores de adn - pk |
| US8431110B2 (en) | 2005-05-23 | 2013-04-30 | Hmi Medical Innovations, Llc. | Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators |
| TW200745094A (en) * | 2005-08-31 | 2007-12-16 | Kudos Pharm Ltd | ATM inhibitor |
| JP4659769B2 (ja) * | 2007-01-25 | 2011-03-30 | トヨタ自動車株式会社 | 冷却装置 |
| UY31232A1 (es) * | 2007-07-19 | 2009-03-02 | Compuestos derivados de dibenzotifenilamino-cromen-4-onas activas sustituidas y sus isomeros y aplicaciones | |
| BR112014002407A2 (pt) | 2011-08-30 | 2017-02-21 | Toyama Chemical Co Ltd | método para melhorar a terapia contra doenças autoimunes tais como artrite reumatóide |
| TWI583677B (zh) * | 2012-09-21 | 2017-05-21 | 日本臟器製藥股份有限公司 | 香豆素衍生物 |
| HUE034661T2 (en) * | 2013-07-18 | 2018-02-28 | Toyama Chemical Co Ltd | A therapeutic agent for diseases based on the inhibitory effect of macrophage migration inhibition factor |
| EP3106161B1 (de) | 2014-02-14 | 2019-09-25 | FUJIFILM Toyama Chemical Co., Ltd. | Präventions- oder behandlungsmittel für speicherkrankheiten von zerebraler amyloid-beta |
| JP6089055B2 (ja) * | 2014-03-20 | 2017-03-01 | 日本臓器製薬株式会社 | クマリン誘導体を含有する医薬 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0753725B2 (ja) * | 1987-10-08 | 1995-06-07 | 富山化学工業株式会社 | ４ｈ―１―ベンゾピラン―４―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤 |
| GB8907799D0 (en) * | 1989-04-06 | 1989-05-17 | Erba Carlo Spa | Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases |
| JP3086312B2 (ja) * | 1991-10-28 | 2000-09-11 | 富山化学工業株式会社 | インターロイキン６の産生抑制剤並びにその産生抑制作用が有効な疾患の治療・予防剤 |
-
1994
- 1994-04-07 US US08/530,177 patent/US5922755A/en not_active Expired - Lifetime
- 1994-04-07 WO PCT/JP1994/000585 patent/WO1994023714A1/ja active IP Right Grant
- 1994-04-07 AU AU64371/94A patent/AU698990B2/en not_active Expired
- 1994-04-07 DK DK94912070T patent/DK0695547T3/da active
- 1994-04-07 AT AT94912070T patent/ATE203904T1/de active
- 1994-04-07 CA CA002159192A patent/CA2159192C/en not_active Expired - Lifetime
- 1994-04-07 JP JP52297194A patent/JP3521145B2/ja not_active Expired - Lifetime
- 1994-04-07 NZ NZ263620A patent/NZ263620A/xx not_active IP Right Cessation
- 1994-04-07 EP EP94912070A patent/EP0695547B1/de not_active Expired - Lifetime
- 1994-04-07 DE DE69427907T patent/DE69427907T2/de not_active Expired - Lifetime
- 1994-04-07 ES ES94912070T patent/ES2160626T3/es not_active Expired - Lifetime
- 1994-04-07 KR KR1019950704375A patent/KR960701633A/ko not_active Application Discontinuation
- 1994-04-07 PT PT94912070T patent/PT695547E/pt unknown
-
1999
- 1999-07-02 US US09/346,932 patent/US6166068A/en not_active Expired - Lifetime
-
2001
- 2001-09-27 GR GR20010401595T patent/GR3036738T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT695547E (pt) | 2001-12-28 |
| ES2160626T3 (es) | 2001-11-16 |
| KR960701633A (ko) | 1996-03-28 |
| JP3521145B2 (ja) | 2004-04-19 |
| US6166068A (en) | 2000-12-26 |
| EP0695547B1 (de) | 2001-08-08 |
| CA2159192C (en) | 2006-07-25 |
| DK0695547T3 (da) | 2001-10-08 |
| DE69427907D1 (de) | 2001-09-13 |
| EP0695547A1 (de) | 1996-02-07 |
| CA2159192A1 (en) | 1994-10-27 |
| AU698990B2 (en) | 1998-11-19 |
| ATE203904T1 (de) | 2001-08-15 |
| EP0695547A4 (de) | 1997-05-28 |
| AU6437194A (en) | 1994-11-08 |
| DE69427907T2 (de) | 2002-04-04 |
| NZ263620A (en) | 1999-06-29 |
| US5922755A (en) | 1999-07-13 |
| WO1994023714A1 (en) | 1994-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3036738T3 (en) | Immunomodulator, cell adhesion inhibitor, and agent for treating and preventing autoimmune diseases | |
| GR3019504T3 (en) | Organic composition containing a fluoroalkyl sulfonic acid salt | |
| AU1086492A (en) | Modified cementitious composition | |
| AU1929088A (en) | Polyethylene glycol carbamates | |
| ATE68804T1 (de) | Stabilisierung von beschichtungsmassen mit hohem feststoffgehalt durch synergistisch wirkende verbindungen. | |
| YU48892B (sh) | Novi steroidi | |
| AU3509789A (en) | Benzamide protease inhibitors | |
| ATE109484T1 (de) | Thienopyridin -derivative und diese enthaltende arzneimittel. | |
| IE900260L (en) | Derivatives of benzocycloalkenyldihydroxyalkanoic acids,¹processes of preparation and medications containing them | |
| TW272974B (de) | ||
| GR3029292T3 (en) | Orthopedic casting tape | |
| GR3036836T3 (en) | Sulfur-containing heterocyclic compounds. | |
| ES2074828T3 (es) | Copoliester degradable de 4-hidroxi-prolina y composicion farmaceutica que lo contiene. | |
| HUP9900865A2 (hu) | Vírusellenes hatású benzimidazolszármazékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények | |
| ZA9410123B (en) | Composition and process for reducing or preventing metal and acid contamination in rock drainage | |
| KR910003073A (ko) | 방염제 및 이를 함유한 방염성 수지조성물 | |
| AU4983790A (en) | Aralkylamine compounds | |
| SE9301732D0 (sv) | New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins | |
| TW326383B (en) | Fungicidal mixture | |
| DK0546547T3 (da) | Farmaceutisk præparat til forbedring af dysuri | |
| EP0627425A4 (de) | ||
| SE8803144L (sv) | Energisubstrat | |
| FI862634A (fi) | Spiro-heteroazaloner foer vaord av komplikationer vid diabetes. | |
| HU9503876D0 (en) | Pharmacologically active enantiomers | |
| ATE71364T1 (de) | Fluor enthaltende vitamin-d2-derivate. |